Seal Shield LLC announces the new Airocide® DS air purifier, a table-top or bedside air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide® converts dangerous bacteria, virus and destructive VOCs into harmless water vapor without producing ozone or other harmful byproducts. Filter-less and energy efficient, Airocide® DS produces air that is 99.999 percent pathogen-free.
While hospitals and other healthcare facilities struggle with the spread of superbugs that contribute to fatal hospital-acquired infections, new evidence shows that "HVAC systems may actually be contributing to transmission of disease" as indicated by the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE). Hospitals manage airborne infectious disease routes by relying on laminar flow diverters, room pressure differentials and HEPA filtration. HEPA filtration's effectiveness is determined by its efficiency with capturing particle sizes .3 microns and above. This is a huge gap considering that numerous pathogens are smaller than .3 microns, including MRSA (.08 um), C.Diff (.07 um), Influenza (.095 um) and Pneumonia (.15 um), to name a few. Furthermore, HEPA filters only "capture" particles and provide no eradication of pathogens.
Seal Shield's Airocide® DS filter-less technology destroys all organic matter, including bacteria and viruses less than .3 microns. In fact, Airocide's eradication capabilities extend down to the smallest organic particles in existence – gas molecules measured in angstrom units. Airocide® even reduces surface contamination by removing airborne organisms that settle on fomites. The Airocide® DS protects the environment by continuously cleaning the air 24 hours a day, every day, with none of the harmful side effects associated with UV products. As a result, Airocide® is the ideal solution to supplement traditional air handling methods in any environment.
The Seal Shield Airocide® DS is currently in stock, and is available for a limited time at a special price of $499 (regularly $799). Seal Shield's infection control products are sold through major distributors worldwide.
Seal Shield designs, develops and manufactures medical grade, infection prevention technology for hospitals and the home including air purification systems, antimicrobial products, waterproof keyboards, mice and TV remote controls.
Source: Seal Shield LLC
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Spring Into Safety: How Seasonal Deep Cleaning Strengthens Hospital Infection Control
June 13th 2025Rooted in ancient rituals of renewal, spring-cleaning has evolved from cultural tradition to a vital infection prevention strategy in modern hospitals—one that blends seasonal deep cleaning with advanced disinfection to reduce pathogens, improve air quality, and protect patients.
AHE Exchange Summit 2025 Brings EVS and Infection Prevention Experts Together in Columbus, Ohio
June 9th 2025The Association for the Health Care Environment (AHE) is set to host its largest event of the year—Exchange Summit 2025—from June 8 to 11 in Columbus, Ohio. With over 600 environmental services (EVS) professionals expected to attend, this year’s conference focuses heavily on infection prevention, interdepartmental collaboration, and education that empowers frontline health care support leaders to improve patient safety and operational efficiency.
Far UV-C Light Shows Promise for Decontaminating Medical Equipment in Clinical Settings
June 4th 2025Manual cleaning gaps on shared hospital equipment can undermine infection control efforts. New research shows far UV-C light can serve as a safe, automated backup to reduce contamination in real-world clinical settings.